Application of tandem mass spectrometry in the screening and diagnosis of mucopolysaccharidoses
- PMID: 38685110
- PMCID: PMC11059687
- DOI: 10.1186/s13023-024-03195-w
Application of tandem mass spectrometry in the screening and diagnosis of mucopolysaccharidoses
Abstract
Mucopolysaccharidoses (MPSs) are caused by a deficiency in the enzymes needed to degrade glycosaminoglycans (GAGs) in the lysosome. The storage of GAGs leads to the involvement of several systems and even to the death of the patient. In recent years, an increasing number of therapies have increased the treatment options available to patients. Early treatment is beneficial in improving the prognosis, but children with MPSs are often delayed in their diagnosis. Therefore, there is an urgent need to develop a method for early screening and diagnosis of the disease. Tandem mass spectrometry (MS/MS) is an analytical method that can detect multiple substrates or enzymes simultaneously. GAGs are reliable markers of MPSs. MS/MS can be used to screen children at an early stage of the disease, to improve prognosis by treating them before symptoms appear, to evaluate the effectiveness of treatment, and for metabolomic analysis or to find suitable biomarkers. In the future, MS/MS could be used to further identify suitable biomarkers for MPSs for early diagnosis and to detect efficacy.
Keywords: Biomarkers; Glycosaminoglycan; Mucopolysaccharidoses; Newborn screening; Tandem mass spectrometry.
© 2024. The Author(s).
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures
Similar articles
-
Newborn screening and diagnosis of mucopolysaccharidoses.Mol Genet Metab. 2013 Sep-Oct;110(1-2):42-53. doi: 10.1016/j.ymgme.2013.06.007. Epub 2013 Jun 21. Mol Genet Metab. 2013. PMID: 23860310 Free PMC article. Review.
-
Advances in glycosaminoglycan detection.Mol Genet Metab. 2020 Jun;130(2):101-109. doi: 10.1016/j.ymgme.2020.03.004. Epub 2020 Mar 27. Mol Genet Metab. 2020. PMID: 32247585 Free PMC article. Review.
-
UPLC-MS/MS detection of disaccharides derived from glycosaminoglycans as biomarkers of mucopolysaccharidoses.Anal Chim Acta. 2016 Sep 14;936:139-48. doi: 10.1016/j.aca.2016.06.054. Epub 2016 Jul 2. Anal Chim Acta. 2016. PMID: 27566349
-
Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.Mol Genet Metab. 2017 Mar;120(3):247-254. doi: 10.1016/j.ymgme.2016.12.010. Epub 2016 Dec 22. Mol Genet Metab. 2017. PMID: 28065440 Free PMC article.
-
Mucopolysaccharidoses Differential Diagnosis by Mass Spectrometry-Based Analysis of Urine Free Glycosaminoglycans-A Diagnostic Prediction Model.Biomolecules. 2023 Mar 15;13(3):532. doi: 10.3390/biom13030532. Biomolecules. 2023. PMID: 36979466 Free PMC article.
Cited by
-
Japanese experience of newborn screening for lysosomal storage diseases and adrenoleukodystrophy.Orphanet J Rare Dis. 2025 Jul 24;20(1):373. doi: 10.1186/s13023-025-03848-4. Orphanet J Rare Dis. 2025. PMID: 40708026 Free PMC article.
References
-
- Arunkumar N, Vu DC, Khan S, Kobayashi H, Can N, Oguni TB, Watanabe T, Tanaka J, Yamaguchi M, Taketani S, Ago T, Ohnishi Y, Saikia H, Álvarez S, Tomatsu S. Diagnosis of mucopolysaccharidoses and mucolipidosis by Assaying Multiplex Enzymes and glycosaminoglycans. Diagnostics (Basel Switzerland) 2021;11(8):1347. doi: 10.3390/diagnostics11081347. - DOI - PMC - PubMed
-
- Auray-Blais C, Lavoie P, Tomatsu S, Valayannopoulos V, Mitchell JJ, Raiman J, Beaudoin M, Maranda B, Clarke JTR. UPLC-MS/MS detection of disaccharides derived from glycosaminoglycans as biomarkers of mucopolysaccharidoses. Anal Chim Acta. 2016;936:139–48. doi: 10.1016/j.aca.2016.06.054. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources